Latest Tissue plasminogen activator Stories
The use of long-distance video and data hookups to link remote community hospitals with stroke neurologists in large centres provides the same level of care as having everyone in the same room.
Using long-distance video and data hookups in remote community hospitals to treat stroke, provides the same level of care as having everyone in the same room, according to a new study.
The percentage of graduating neurology residents comfortable treating stroke with a clot-busting drug has increased dramatically over the past 10 years.
A naturally occurring substance shrank the size of stroke-induced lesions in the brains of experimental mice â€” even when administered as much as 12 hours after the event, Stanford University School of Medicine researchers have shown.
A citywide study published online in todayâ€™s issue of Stroke: Journal of the American Heart Association demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke.
African-Americans are less likely than whites to receive critical stroke treatment primarily because they do not get to a hospital soon enough for time-sensitive treatment and because of preexisting medical conditions.
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 â€” but is still low.
A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective.
Strokes are not typically thought of as a childhood health issue, but Baylor College of Medicine experts warn that they do occur in children and can result in significant long-lasting effects.
Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment.